Susquehanna International Group
TARO

Susquehanna International Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Susquehanna International Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,000
Closed -$296K – 13507
2024
Q1 		$296K Buy
+7,000
New +$295K ﹤0.01% 9721
2019
Q2 		– Sell
-2,100
Closed -$227K – 10974
2019
Q1 		$227K Buy
+2,100
New +$209K ﹤0.01% 7690
2018
Q3 		– Sell
-2,600
Closed -$301K – 10448
2018
Q2 		$301K Buy
+2,600
New +$286K ﹤0.01% 7843
2018
Q1 		– Sell
-2,200
Closed -$230K – 10369
2017
Q4 		$230K Buy
+2,200
New +$242K ﹤0.01% 8029
2017
Q3 		– Sell
-1,900
Closed -$213K – 9794
2017
Q2 		$213K Buy
+1,900
New +$215K ﹤0.01% 8187
2017
Q1 		– Sell
-3,400
Closed -$358K – 10193
2016
Q4 		$358K Sell
3,400
-5,200
-60% -$545K ﹤0.01% 7630
2016
Q3 		$950K Sell
8,600
-5,800
-40% -$768K ﹤0.01% 4910
2016
Q2 		$2.1M Buy
14,400
+9,800
+213% +$1.39M ﹤0.01% 3490
2016
Q1 		$659K Sell
4,600
-12,000
-72% -$1.7M ﹤0.01% 5903
2015
Q4 		$2.57M Buy
16,600
+8,500
+105% +$1.24M ﹤0.01% 3584
2015
Q3 		$1.16M Sell
8,100
-33,100
-80% -$4.63M ﹤0.01% 5420
2015
Q2 		$5.92M Sell
41,200
-3,300
-7% -$471K ﹤0.01% 2659
2015
Q1 		$6.28M Buy
44,500
+37,100
+501% +$5.71M ﹤0.01% 2424
2014
Q4 		$1.1M Buy
7,400
+5,600
+311% +$823K ﹤0.01% 5682
2014
Q3 		$277K Sell
1,800
-3,500
-66% -$527K ﹤0.01% 8149
2014
Q2 		$743K Buy
+5,300
New +$588K ﹤0.01% 6680

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Susquehanna International Group's TARO Position: Q1 2024 in Review

Susquehanna International Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 6,668 shares — an estimated $281K sold.

Susquehanna International Group first reported a position in TARO in Q2 2014 and held it in 22 quarters. The position peaked at $5.1M in Q4 2017. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Susquehanna International Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 6,668 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $281K.
  • Susquehanna International Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 22 quarters.
  • Susquehanna International Group's Taro Pharmaceutical Industries Ltd. position peaked at $5.1M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.